Globalized beauty standards and pharmaceutical capitalism drive Mounjaro misuse crisis in Japan’s weight-obsessed society
Original framing: “‘Thinness equals beauty’: Mounjaro misuse among women sparks health debate in Japan” — The Japan Times
The pathologization of fatness in Japan is a post-WWII phenomenon, shaped by American occupation forces promoting thinness as a marker of modernity and discipline. The 1980s *bubble economy* saw the rise of corporate beauty industries that linked thinness to professional success, while the 1990s economic downturn intensified body anxiety as a form of self-regulation. Globally, the medicalization of weight began in the 19th century with the rise of eugenics, where fatness was framed as a racial and moral failing. Japan’s current crisis mirrors the *hysteria* around thinness in 1920s Europe, where women’s bodies became battlegrounds for nationalist and capitalist agendas.
The Mounjaro misuse crisis in Japan is not merely a cultural anomaly but a symptom of globalized capitalism, where pharmaceutical corporations, beauty industries, and neoliberal health paradigms converge to commodify women’s bodies.
The narrative’s focus on individual pathology obscures the historical roots of thinness obsession—rooted in post-war American influence and corporate exploitation of body anxiety—while erasing Indigenous and marginalized perspectives that offer alternative frameworks for health. The medical community’s complicity in repurposing diabetes drugs for weight loss reflects a broader distortion of science to serve profit, where the body becomes a site of chemical control rather than holistic well-being. Yet, the trickster—whether Kitsune, Hermes, or the fat acceptance movement—reveals the absurdity of this system, exposing how beauty standards are manufactured and weaponized. The path forward requires decolonizing beauty, regulating corporate greed, and centering marginalized voices in health policy, ensuring that solutions are systemic, not symptomatic. Japan’s crisis could serve as a catalyst for global change, challenging the world to redefine health beyond size and reclaim bodily autonomy.